APA (7th ed.) Citation

Sun, M., Jing, H., Qu, X., Dong, F., Li, Y., Feng, Z., . . . Qiu, L. (2024). Phase 1 study of isatuximab monotherapy in Chinese patients with relapsed/refractory multiple myeloma. Scientific Reports, 14(1), 1. https://doi.org/10.1038/s41598-024-59186-1

Chicago Style (17th ed.) Citation

Sun, Mingyuan, et al. "Phase 1 Study of Isatuximab Monotherapy in Chinese Patients with Relapsed/refractory Multiple Myeloma." Scientific Reports 14, no. 1 (2024): 1. https://doi.org/10.1038/s41598-024-59186-1.

MLA (9th ed.) Citation

Sun, Mingyuan, et al. "Phase 1 Study of Isatuximab Monotherapy in Chinese Patients with Relapsed/refractory Multiple Myeloma." Scientific Reports, vol. 14, no. 1, 2024, p. 1, https://doi.org/10.1038/s41598-024-59186-1.